Charisma Studie
Laufzeit: 01.01.2003 - 31.12.2006
imported
Kurzfassung
Clopidogrel for High Artherothrombotic Risk am Ischemic Stabilization, Management and Avoidance (CHARISMA)
Laufzeit: 01.01.2003 - 31.12.2006
Clopidogrel for High Artherothrombotic Risk am Ischemic Stabilization, Management and Avoidance (CHARISMA)